-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
B7-H3 is a cell surface immunomodulatory glycoprotein
that is overexpressed in prostate cancer (PC).
Recently, researchers from the United Kingdom published an article in Eur Urol investigating the expression of B7-H3 in hormone-sensitive (HSPC) and castration-resistant (CRPC) PC biopsy tissues in the same patient and linked
to PC genomics.
The researchers performed immunohistochemistry and next-generation sequencing of 98 clinically annotated CRPC living tissues, including 72 patients who
also had HSPC living tissue.
The study found that B7-H3 is one of
the most highly expressed immunomodulatory genes in CRPCs.
Anti-tumor activity of anti-B7-H3 ADCs in human CRPC models
Taken together, B7-H3 is often overexpressed in CRPC compared to normal tissues and other members of the B7 family, meaning it may be a highly probable therapeutic target for these diseases
.
Original Source:
Christina Guo, Ines Figueiredo, Bora Gurel et al.